StonvexLoading…
StonvexStonvexStonvexCore line items from NNBR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $118.45M | $422.21M | $317.49M | $213.61M |
Operating Income | $-2.06M | $-18.91M | $-8.50M | $-6.25M |
Net Income | $-6.83M | $-34.00M | $-21.47M | $-14.79M |
EPS (Diluted) | $-0.25 | $-1.07 | $-0.72 | $-0.48 |
Total Assets | $453.43M | $440.78M | $450.96M | $460.76M |
Total Liabilities | $309.48M | $294.38M | $294.04M | $298.70M |
Cash & Equivalents | $8.47M | $11.38M | $12.21M | $9.54M |
Free Cash Flow OCF − CapEx | $-11.92M | $-7.25M | $-3.93M | $-11.67M |
Shares Outstanding | 52.79M | 50.20M | 50.20M | 50.29M |